MIT develops nano 'protein factories'; RNA molecules show signs of halting head and neck cancer;

> Protein-based drugs sometimes struggle to reach their targets after bodily fluids degrade their casings. In response, MIT has developed a nanoparticle that can synthesize proteins on demand using materials from the body. Story

> Researchers at the California Institute of Technology have developed a nanoparticle that delivers siRNA and has shown promise in treating head and neck cancer in animal testing. Article

> Israel's Ben-Gurion University has licensed its V-Smart drug delivery platform to New York's Lauren Sciences, which will use it to develop treatments for central nervous system disorders. News

> Scientists at Rice University may have found a new way to get drugs directly into cancer cells using light-harvesting nanoparticles to transform laser energy into "nanobubbles." Rice University release

Suggested Articles

Takeda forged a feasibility pact to see whether it could pair a plasma-based therapy with Elektrofi's microparticle delivery tech.

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.